Has Lindsey Fix, MD received payments from drug or device companies?

Yes. Drug and device makers reported $5,174 in general payments to Lindsey Fix, MD across 224 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Lindsey Fix, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Lindsey Fix, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Lindsey Fix, MD

MOHS-Micrographic Surgery · Springfield, ORNPI 1972913259

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.2% of the total across 224 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 22.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,328, 3.5 times the $384 reported in 2019.

$5,174in general payments, 2019–2025

Across 224 payments — averaging $23.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$1K
AbbVie$802
Regeneron Healthcare Solutions, Inc.$643
Lilly USA, LLC$538
Sanofi$358
Janssen Scientific Affairs, LLC$251
plus $1K from 15 others

What the payments were for

Food & beverage$4,92595%
Education$2495%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	65	$1,182
AbbVie	44	$802
Regeneron Healthcare Solutions, Inc.	12	$643
Lilly USA, LLC	25	$538
Sanofi	17	$358
Janssen Scientific Affairs, LLC	2	$251
E.r. Squibb & Sons, L.L.C.	7	$241
UCB, Inc.	7	$239
Amgen	14	$212
Genentech USA, Inc.	6	$136
Incyte Corporation	3	$114
Novartis	6	$112
Pfizer	4	$99
Sanofi-aventis U.S. LLC	1	$80
Sun Pharmaceutical Industries Inc.	2	$37
Biocon Biologics Inc	2	$36
Helsinn Therapeutics (U.S.), Inc.	2	$28
DUSA Pharmaceuticals, Inc.	1	$19
Strata Skin Sciences, Inc.	2	$18
Kyowa Kirin, Inc.	1	$16
Ortho Dermatologics, A Division Of Bausch Health US, LLC	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Tremfya$374
LIBTAYO$135
DUPIXENT$111
TALTZ$106
Skyrizi$101

How this compares

Too few mohs-micrographic surgery providers in Oregonto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024

$287,747

Medicare patients

519

Services billed

2,345

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Clobetasol Propionate	116	$5,989
Doxycycline Hyclate	44	$1,229
Metronidazole	22	$983
Clindamycin Phosphate	23	$911
Triamcinolone Acetonide	98	$850
Ketoconazole	42	$829
Fluorouracil	13	$654
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc	15	$563
Desonide	13	$560
Fluconazole	55	$518
Cephalexin	13	$339
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip	13	$330
Minoxidil	25	$283
Hydroxyzine Hcl	29	$268
Mupirocin	29	$241

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Springfield

Anna BarPortland$63K
Wesley YuPortland$15K
Oliver WiscoBend$13K
Jarett CasaleSalem$6K
Gerald PetersBend$3K
Jennifer BarklundMedford$2K
Tamar HajarPortland$2K
Nolan MaloneyMedford$2K
William LearSalem$1K
Sarah FitzmauricePortland$963

See the full list for Oregon →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →